Tissue Regenix Group PLC Interim Results and Capital Markets Day (9773U)
October 22 2014 - 4:01AM
UK Regulatory
TIDMTRX
RNS Number : 9773U
Tissue Regenix Group PLC
22 October 2014
Tissue Regenix Group Plc
("Tissue Regenix" or "the Company")
Interim Results and Capital Markets Day
YORK, 22(nd) October, 2014 - Tissue Regenix Group plc (AIM:TRX)
("Tissue Regenix" or "the Group"), the regenerative medical devices
company which uses animal or human tissue to replace damaged or
worn out parts of the human body, advises that it will be
announcing its unaudited interim results for the six months ended
31 July 2014, on Wednesday 29th October, 2014.
In addition, the Company will be hosting a Capital Markets Event
on Wednesday 29th October 2014, with presentations and updates from
senior management. Those wishing to attend should register their
interest with Newgate Communications.
For Further Information
Tissue Regenix Group Plc: +44 19 0443 5176
Antony Odell
Ian Jefferson
Jefferies International Ltd: +44 20 7029 8000
Simon Hardy
Harry Nicholas
Newgate Communications: +44 207 6806550
Andrew Adie
Deborah Saw
About Tissue Regenix
Tissue Regenix is a leading medical devices company in the field
of regenerative medicine. The company's patented decellularisation
('dCELL(R)') technology removes DNA and other cellular material
from animal and human tissue leaving an acellular tissue scaffold
which is not rejected by the patient's body which can then be used
to repair diseased or worn out body parts. The potential
applications of this process are diverse and address many critical
clinical needs such as vascular disease, heart valve replacement
and knee repair.
Tissue Regenix was formed in 2006 when it was spun-out from the
University of Leeds. The company commercialises academic research
conducted by our partners around the World.
In November 2012 Tissue Regenix Group plc set up a subsidiary
company in the United States- 'Tissue Regenix Wound Care Inc.', as
part of its commercialisation strategy for its dCELL(R) technology
platform.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NOREAXEAAEXLFEF
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Tissue Regenix (LSE:TRX)
Historical Stock Chart
From Sep 2023 to Sep 2024